Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emerging Indications for Hyperbaric Oxygen Treatment
NCT07240649Phase 4Not yet recruiting
- Start
- Nov 2026
- Primary completion
- Dec 2035
01
Overview
A Phase 4 trial of oxygen in post-COVID-19 condition (PCC), ulcerative colitis (UC), Crohn's disease, calciphylaxis (CUA), frostbite. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
oxygen
03
Conditions
post-COVID-19 condition (PCC)ulcerative colitis (UC)Crohn's diseasecalciphylaxis (CUA)frostbite
Beyond the preview
Go deeper on NCT07240649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07240649.